300026 红日药业
已收盘 07-23 15:00:00
资讯
新帖
简况
SPD(医疗供应链管理)概念盘中跳水,红日药业跌1.29%
自选股智能写手 · 07-10
SPD(医疗供应链管理)概念盘中跳水,红日药业跌1.29%
红日药业新注册《供应商分析平台V1.0》项目的软件著作权
证券之星 · 07-01
红日药业新注册《供应商分析平台V1.0》项目的软件著作权
红日药业新提交2件商标注册申请
证券之星 · 06-29
红日药业新提交2件商标注册申请
6月20日红日药业创60日新低,银河医药混合A基金重仓该股
证券之星 · 06-20
6月20日红日药业创60日新低,银河医药混合A基金重仓该股
红日药业(300026)6月13日主力资金净卖出1965.87万元
证券之星 · 06-14
红日药业(300026)6月13日主力资金净卖出1965.87万元
红日药业(300026.SZ)2023年度拟每10股派0.3元 5月23日除权除息
智通财经 · 05-16
红日药业(300026.SZ)2023年度拟每10股派0.3元 5月23日除权除息
红日药业(300026.SZ)发布一季度业绩,净利润5812.09万元,下降66.87%
智通财经 · 04-25
红日药业(300026.SZ)发布一季度业绩,净利润5812.09万元,下降66.87%
红日药业最新公告:一季度净利润同比下降66.87%
证券之星 · 04-25
红日药业最新公告:一季度净利润同比下降66.87%
红日药业:缬沙坦氨氯地平片(Ⅰ)获得药品注册证书 有助于丰富公司产品种类
中国财富通 · 04-24
红日药业:缬沙坦氨氯地平片(Ⅰ)获得药品注册证书 有助于丰富公司产品种类
红日药业(300026.SZ)获高血压药“缬沙坦氨氯地平片(Ⅰ)”药品注册证书
智通财经 · 04-24
红日药业(300026.SZ)获高血压药“缬沙坦氨氯地平片(Ⅰ)”药品注册证书
红日药业将于4月22日召开股东大会,共审议8项议案
金融界网站 · 03-28
红日药业将于4月22日召开股东大会,共审议8项议案
红日药业(300026.SZ)发预减,预计2023年净利润5.02亿元至5.38亿元,同比下降13.82%至19.58%
智通财经网 · 01-30
红日药业(300026.SZ)发预减,预计2023年净利润5.02亿元至5.38亿元,同比下降13.82%至19.58%
公司概况
公司名称:
天津红日药业股份有限公司
所属行业:
医药制造业
上市日期:
2009-10-30
主营业务:
天津红日药业股份有限公司是一家主要从事药品及医疗器械的生产经营和研究开发,主要产品包括:血必净注射液、盐酸法舒地尔注射液(川威)、低分子量肝素钙注射液(博璞青)、中药配方颗粒、医疗器械、药用辅料等。公司获得国家发改委发布的全国制药行业企业信用评价AAA级,荣获国家知识产权优势企业、全国药品不良反应监测评价工作优秀单位称号,公司“新药转移突击队”获评“全国工人先锋号”,获得中国医药工业百强企业排名第41位,中成药企业百强第15位。
发行价格:
60.00
{"stockData":{"symbol":"300026","market":"SZ","secType":"STK","nameCN":"红日药业","latestPrice":3.13,"timestamp":1721718192000,"preClose":3.19,"halted":0,"volume":21613753,"delay":0,"floatShares":2753000000,"shares":3004000000,"eps":0.1296,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.06,"latestTime":"07-23 15:00:00","open":3.18,"high":3.19,"low":3.12,"amount":68204400,"amplitude":0.0219,"askPrice":3.13,"askSize":2556,"bidPrice":3.12,"bidSize":5986,"shortable":0,"etf":0,"ttmEps":0.1296,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721784600000},"adr":0,"adjPreClose":3.19,"symbolType":"stock","openAndCloseTimeList":[[1721698200000,1721705400000],[1721710800000,1721718000000]],"highLimit":3.51,"lowLimit":2.87,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":3004154837,"pbRate":1.09,"roa":"--","roe":"0.67%","epsLYR":0.17,"committee":-0.032682,"marketValue":9403000000,"floatMarketCap":8617000000,"peRate":24.151234,"changeRate":-0.0188,"turnoverRate":0.0079,"status":1},"requestUrl":"/m/hq/s/300026/wiki","defaultTab":"wiki","newsList":[{"id":"2450881773","title":"SPD(医疗供应链管理)概念盘中跳水,红日药业跌1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450881773","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450881773?lang=zh_cn&edition=full","pubTime":"2024-07-10 09:37","pubTimestamp":1720575438,"startTime":"0","endTime":"0","summary":"07月10日,SPD(医疗供应链管理)概念盘中跳水,截至09点37分,SPD(医疗供应链管理)概念整体指数下跌0.55%,报821.750点。从个股上来看,该概念的成分股中,红日药业跌1.29%,合富中国、柳药集团、国新健康跌幅居前。从资金上来看,截止发稿,SPD(医疗供应链管理)概念主力净流入为-373.95万,其中合富中国受到资金热捧,主力净流入122.43万;拉长时间线来看,该板块近20日主力资金净流入-4.52亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100937189681b492&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100937189681b492&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300026","BK0077","603122","BK0188","BK0239","159891","BK0250"],"gpt_icon":0},{"id":"2448602902","title":"红日药业新注册《供应商分析平台V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2448602902","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448602902?lang=zh_cn&edition=full","pubTime":"2024-07-01 01:15","pubTimestamp":1719767737,"startTime":"0","endTime":"0","summary":"证券之星消息,近日红日药业(300026)新注册了《供应商分析平台V1.0》项目的软件著作权。今年以来红日药业新注册软件著作权4个,较去年同期减少了0%。结合公司2023年年报财务数据,2023年公司在研发方面投入了2.16亿元,同比减8.91%。数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070100000844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","BK0239","300026"],"gpt_icon":0},{"id":"2447566124","title":"红日药业新提交2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2447566124","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2447566124?lang=zh_cn&edition=full","pubTime":"2024-06-29 12:32","pubTimestamp":1719635568,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日天津红日药业股份有限公司新提交2件商标注册申请。商标申请详情如下:今年以来天津红日药业股份有限公司新申请注册商标2件,截止目前公司共持有注册商标358件,另有6件商标尚在注册申请中。数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062900013686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0077","300026"],"gpt_icon":0},{"id":"2444262578","title":"6月20日红日药业创60日新低,银河医药混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2444262578","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444262578?lang=zh_cn&edition=full","pubTime":"2024-06-20 16:24","pubTimestamp":1718871887,"startTime":"0","endTime":"0","summary":"证券之星消息,6月20日红日药业创60日新低,收盘报3.12元,当日跌2.8%,换手率0.93%,成交量25.68万手,成交额8124.96万元。重仓红日药业的公募基金请见下表:根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为银河医药混合A。银河医药混合A目前规模为5.02亿元,最新净值0.4719,较上一交易日下跌1.4%,近一年下跌23.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062000030250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0188","300026","BK1515","09939","BK0239","BK1574","159938","BK0077"],"gpt_icon":0},{"id":"2443661024","title":"红日药业(300026)6月13日主力资金净卖出1965.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443661024","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443661024?lang=zh_cn&edition=full","pubTime":"2024-06-14 09:21","pubTimestamp":1718328104,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年6月13日收盘,红日药业报收于3.28元,下跌2.96%,换手率1.43%,成交量39.48万手,成交额1.3亿元。近5日资金流向一览见下表:红日药业融资融券信息显示,融资方面,当日融资买入1066.37万元,融资偿还684.96万元,融资净买入381.41万元,连续3日净买入累计807.07万元。融券方面,融券卖出23.69万股,融券偿还33.17万股,融券余量199.72万股,融券余额655.08万元。红日药业主营业务:药品及医疗器械的生产经营和研究开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061400013207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","300026","BK0077","BK0239"],"gpt_icon":0},{"id":"2435621040","title":"红日药业(300026.SZ)2023年度拟每10股派0.3元 5月23日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2435621040","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435621040?lang=zh_cn&edition=full","pubTime":"2024-05-16 17:14","pubTimestamp":1715850866,"startTime":"0","endTime":"0","summary":"智通财经APP讯,红日药业(300026.SZ)公告,公司2023年度拟向全体股东每10股派0.30元人民币现金(含税),本次权益分派股权登记日为2024年5月22日,除权除息日为2024年5月23日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1122039.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK0188","300026","BK0239"],"gpt_icon":0},{"id":"2430283368","title":"红日药业(300026.SZ)发布一季度业绩,净利润5812.09万元,下降66.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430283368","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430283368?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:14","pubTimestamp":1714050846,"startTime":"0","endTime":"0","summary":"智通财经APP讯,红日药业(300026.SZ)发布2024年第一季度报告,该公司营业收入为14.63亿元,同比减少11.80%。归属于上市公司股东的净利润为5812.09万元,同比减少66.87%。归属于上市公司股东的扣除非经常性损益的净利润为5417.91万元,同比减少65.46%。基本每股收益为0.02元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300026"],"gpt_icon":0},{"id":"2430401592","title":"红日药业最新公告:一季度净利润同比下降66.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430401592","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430401592?lang=zh_cn&edition=full","pubTime":"2024-04-25 19:50","pubTimestamp":1714045819,"startTime":"0","endTime":"0","summary":"红日药业发布2024年第一季度报告,实现营业收入14.63亿元,同比下降11.80%。归属于上市公司股东的净利润5812.09万元,同比下降66.87%;基本每股收益0.02元。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500041734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300026"],"gpt_icon":0},{"id":"2429482061","title":"红日药业:缬沙坦氨氯地平片(Ⅰ)获得药品注册证书 有助于丰富公司产品种类","url":"https://stock-news.laohu8.com/highlight/detail?id=2429482061","media":"中国财富通","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429482061?lang=zh_cn&edition=full","pubTime":"2024-04-24 17:05","pubTimestamp":1713949559,"startTime":"0","endTime":"0","summary":"中国财富通4月24日 - 红日药业(300026)公告称,公司于近日收到国家药品监督管理局下发的药品注册证书,药品名称为缬沙坦氨氯地平片(Ⅰ)。公司产品缬沙坦氨氯地平片(Ⅰ)获得国家药品监督管理局的《药品注册证书》,标志着公司具备了在国内市场销售该药品的资格,丰富了公司产品种类。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=PeNYRZtYjUM%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","300026","BK0077","BK0188"],"gpt_icon":0},{"id":"2429481002","title":"红日药业(300026.SZ)获高血压药“缬沙坦氨氯地平片(Ⅰ)”药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2429481002","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429481002?lang=zh_cn&edition=full","pubTime":"2024-04-24 16:45","pubTimestamp":1713948340,"startTime":"0","endTime":"0","summary":"智通财经APP讯,红日药业(300026.SZ)公告,公司于近日收到国家药品监督管理局下发的“缬沙坦氨氯地平片(Ⅰ)”药品注册证书。据悉,该产品用于治疗原发性高血压。用于单药治疗不能充分控制血压的患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1108488.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK0239","BK0077","300026"],"gpt_icon":0},{"id":"2422110190","title":"红日药业将于4月22日召开股东大会,共审议8项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2422110190","media":"金融界网站","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422110190?lang=zh_cn&edition=full","pubTime":"2024-03-28 22:05","pubTimestamp":1711634700,"startTime":"0","endTime":"0","summary":"转自:金融界本文源自:金融界金融界3月28日消息,红日药业发布公告,将于2024年4月22日召开年度股东大会,网络投票同日进行。股权登记日为4月16日,当日收市后持有红日药业股票的投资者可以参与投票。会议地点:天津市武清开发区创业总部基地B01号楼天津红日药业股份有限公司会议室。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-03-28/doc-inapwvci4266811.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-03-28/doc-inapwvci4266811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0077","BK0239","300026"],"gpt_icon":0},{"id":"2407438968","title":"红日药业(300026.SZ)发预减,预计2023年净利润5.02亿元至5.38亿元,同比下降13.82%至19.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2407438968","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2407438968?lang=zh_cn&edition=full","pubTime":"2024-01-30 16:56","pubTimestamp":1706604960,"startTime":"0","endTime":"0","summary":"红日药业(300026.SZ)披露2023年年度业绩预告,公司预计归属于上市公司股东的净利润5.02亿元至5.38亿元,同比下降13.82%至19.58%;扣除非经常性损益后的净利润3.71亿元至4.42亿元,同比下降22.56%至35.00%。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-30/doc-inafhxve7197584.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-30/doc-inafhxve7197584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300026"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2009-10-30","address":"天津市武清区新技术产业园区武清开发区泉发路西","stockEarnings":[{"period":"1week","weight":0.0192},{"period":"1month","weight":0.0192},{"period":"3month","weight":-0.1284},{"period":"6month","weight":-0.1425},{"period":"1year","weight":-0.3779},{"period":"ytd","weight":-0.2416}],"companyName":"天津红日药业股份有限公司","boardCode":"AI0027","perCapita":"23201股","boardName":"医药制造业","registeredCapital":"300415万元","compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0113},{"period":"3month","weight":-0.0191},{"period":"6month","weight":0.0509},{"period":"1year","weight":-0.0642},{"period":"ytd","weight":-0.0036}],"survey":" 天津红日药业股份有限公司是一家主要从事药品及医疗器械的生产经营和研究开发,主要产品包括:血必净注射液、盐酸法舒地尔注射液(川威)、低分子量肝素钙注射液(博璞青)、中药配方颗粒、医疗器械、药用辅料等。公司获得国家发改委发布的全国制药行业企业信用评价AAA级,荣获国家知识产权优势企业、全国药品不良反应监测评价工作优秀单位称号,公司“新药转移突击队”获评“全国工人先锋号”,获得中国医药工业百强企业排名第41位,中成药企业百强第15位。","serverTime":1721750483937,"listedPrice":60,"stockholders":"118651人(较上一季度减少0.29%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"红日药业(300026)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供红日药业(300026)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"红日药业,300026,红日药业股票,红日药业股票老虎,红日药业股票老虎国际,红日药业行情,红日药业股票行情,红日药业股价,红日药业股市,红日药业股票价格,红日药业股票交易,红日药业股票购买,红日药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"红日药业(300026)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供红日药业(300026)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}